Torrent Pharma Q4 FY26 results: Revenue jumps 42% YoY, profit at Rs 389 crore, dividend announced
Published on: May 22, 2026, 7:20 p.m. | Source: The Financial Express
Torrent Pharmaceuticals reported a 42 percent rise in Q4 FY26 revenue, driven by strong domestic business growth and a successful semaglutide launch. The company also posted higher annual profit, announced a final dividend, and strengthened its leadership position across multiple chronic therapy segments in India.
